Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Visible Light Photoredox Catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN117362140A reveals a photoredox synthesis method for cyclohexyl substituted styrenes. Achieve high purity and cost reduction in pharmaceutical intermediate manufacturing with scalable visible-light catalysis.
Patent CN116730915A enables metal-free asymmetric catalysis. Offers high purity pharmaceutical intermediates with reduced cost and scalable supply chain solutions.
Patent CN103467282A details a mild, iridium-catalyzed visible light method for synthesizing polysubstituted naphthols, offering significant cost reduction and supply chain reliability for pharmaceutical intermediates.
Patent CN115108875A reveals a metal-free visible light asymmetric method for synthesizing nitrogen-containing chiral cyclic alcohols, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Novel visible-light method for quinoline intermediates. Reduces cost and improves supply chain reliability for anti-tumor drug development.
Patent CN110386854A reveals a metal-free photoredox method for aryl alkynes. This report analyzes cost reduction in pharmaceutical intermediate manufacturing and supply chain reliability.
Patent CN114456207B reveals a green visible light nickel catalyzed method for chiral beta-aryl ketones, offering cost reduction and scalable supply for pharmaceutical intermediates.
Patent CN109134326B details a mild, visible-light catalyzed synthesis of S-aryl thiosulfones using thiourea and metabisulfite, offering significant cost and safety advantages for pharmaceutical intermediate manufacturing.
Patent CN110698360A details a green visible-light method for amide synthesis. Discover cost-effective, metal-free manufacturing solutions for high-purity pharmaceutical intermediates.
Novel photoredox method for alpha,alpha-difluoro-beta-carbonyl sulfones using visible light, offering mild conditions and broad substrate scope for pharma intermediates.
Patent CN110698369B reveals a mild visible-light method for synthesizing arylacetylene alkyl sulfones using alkyl fluoroborates, offering significant cost and safety advantages for pharmaceutical intermediate manufacturing.
Discover the novel photocatalytic synthesis of heterocyclic cyclopropanes from patent CN112898202B. A mild, high-yield route for pharmaceutical intermediates manufacturing.
Patent CN114213254B details a novel photoredox method for beta-nitroketones. Enables cost reduction in pharmaceutical intermediate manufacturing with high yields.